463 related articles for article (PubMed ID: 18539004)
21. Use of ampicillin/sulbactam (sultamicillin) in the management of pediatric infections. Introduction.
Arredondo-García JL
Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S3. PubMed ID: 9519906
[No Abstract] [Full Text] [Related]
22. [A study on pharmacokinetics, antimicrobial activity and clinical efficacy of sultamicillin in children].
Okazaki H; Kitamura N; Hirabayashi Y; Higashino H; Kobayashi Y
Jpn J Antibiot; 1988 Dec; 41(12):1940-6. PubMed ID: 3249366
[TBL] [Abstract][Full Text] [Related]
23. [Clinical experience with treatment of childhood infections using sultamicillin--Unasyn (Pfizer)].
Hobstová J; Havlík J
Cesk Pediatr; 1991 Nov; 46(10-11):466-8. PubMed ID: 1786602
[TBL] [Abstract][Full Text] [Related]
24. Sultamicillin in the treatment of obstetric and gynaecological infections.
Samaha I; Said A
J Int Med Res; 1992; 20 Suppl 1():62A-70A. PubMed ID: 1451931
[TBL] [Abstract][Full Text] [Related]
25. [Activity of an ampicillin/sulbactam combination in respiratory infections].
Mangiarotti P; Manara G; Grassi G; Gialdroni Grassi G
G Ital Chemioter; 1989; 36(1-3):39-44. PubMed ID: 2488911
[TBL] [Abstract][Full Text] [Related]
26. The pharmacokinetics of sultamicillin.
Lode H; Hampel B; Bruckner G; Koeppe P
APMIS Suppl; 1989; 5():17-22. PubMed ID: 2660866
[TBL] [Abstract][Full Text] [Related]
27. Delayed cerebrospinal fluid sterilization, in vitro bactericidal activities, and side effects of selected beta-lactams.
Dajani AS; Pokowski LH
Scand J Infect Dis Suppl; 1990; 73():31-42. PubMed ID: 2091255
[TBL] [Abstract][Full Text] [Related]
28. [Profile of a new antibiotic: the combination sulbactam/ampicillin].
Barba D; Galante D; Esposito S; Giusti G
Recenti Prog Med; 1987 Jun; 78(6):274-83. PubMed ID: 3310152
[No Abstract] [Full Text] [Related]
29. Clinical use of sultamicillin (ampicillin/sulbactam) in children.
López EL; Rivas NA
Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S12-4; discussion S20-1. PubMed ID: 9519909
[No Abstract] [Full Text] [Related]
30. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
[TBL] [Abstract][Full Text] [Related]
31. Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infection.
Kerins DM
Am J Med Sci; 1991 Jun; 301(6):406-11. PubMed ID: 2039029
[No Abstract] [Full Text] [Related]
32. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
33. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
[TBL] [Abstract][Full Text] [Related]
34. [Clinical studies on sultamicillin fine granule in pediatric field].
Ishikawa J; Kida K; Matsuda H; Murase M
Jpn J Antibiot; 1988 Dec; 41(12):1965-71. PubMed ID: 3249370
[TBL] [Abstract][Full Text] [Related]
35. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
Jauregui L; Minns P; Hageage G
Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of sulbactam/ampicillin in the pediatric infections].
Meguro H; Arimasu O; Shiraishi H; Sugamata K; Hiruma F; Abe T; Fujii R; Mashiko J; Nagao Y; Okamoto Y
Jpn J Antibiot; 1989 Mar; 42(3):612-22. PubMed ID: 2746845
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.
Fernández-Varón E; Escudero-Pastor E; Cárceles-Rodríguez CM
Vet J; 2005 May; 169(3):437-43. PubMed ID: 15848786
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of ampicillin and sulbactam in pediatric patients.
Nahata MC; Vashi VI; Swanson RN; Messig MA; Chung M
Antimicrob Agents Chemother; 1999 May; 43(5):1225-9. PubMed ID: 10223940
[TBL] [Abstract][Full Text] [Related]
39. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
Thomson JM; Distler AM; Bonomo RA
Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
[TBL] [Abstract][Full Text] [Related]
40. Experience with ampicillin/sulbactam in severe infections.
Kanra G
J Int Med Res; 2002; 30 Suppl 1():20A-30A. PubMed ID: 11921491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
